Results 11 to 20 of about 10,875 (185)
Objective To examine whether education level influences screening, monitoring, and treatment of hypercholesterolemia.Design Epidemiological cohort study.Setting Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre.Subjects ...
Marius Mølsted Flege +6 more
doaj +1 more source
Extreme lipoprotein(a) in clinical practice: A cross sectional study
Introduction: Measurement of lipoprotein(a) [Lp(a)] is recommended once in a lifetime to identify individuals at high risk of atherosclerotic cardiovascular disease (ASCVD).
Barak Zafrir, Amir Aker, Walid Saliba
doaj +1 more source
PCSK9 Antagonists: Clinical Efficacy and Main Trends in the Development of New Medicines
Scientific relevance. Cardiovascular diseases (CVD) are the leading cause of death worldwide. Dyslipidemia, as the pathophysiological basis of atherosclerosis, is the most important cause of CVD.
A. A. Nekipelova, R. N. Alyautdin
doaj +1 more source
Elevated circulating lipoprotein(a) levels are associated with an increased risk of cardiovascular events. We reported that early initiation of evolocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, in addition to a statin substantially ...
Tomoaki Okada +9 more
doaj +1 more source
Antioxidant and Hypolipidemic Activities of Cinnamic Acid Derivatives
Oxidative stress and hyperlipidemia are important factors for the initiation and progression of various cell degenerative pathological conditions, including cardiovascular and neurological diseases.
Christina Nouni +2 more
doaj +1 more source
Inhibition of palmitoyl CoA deacylase by chlorophenoxyisobutyrate and betabenzalbutyrate
Palmitoyl CoA deacylase activity was measured in preparations of rat liver microsomes. Two hypolipidemic agents, chlorophenoxyisobutyrate and betabenzalbutyrate caused inhibition of palmitoyl CoA deacylase in vitro.
Robert G. Lamb +2 more
doaj +1 more source
Background: Lipid-lowering agents are now the cornerstone of treatment used to reduce the risk of coronary events. Since there is wide variation in selection and use of these drugs, drug utilization studies help to evaluate and analyze drug therapy from ...
Seema Gupta +6 more
doaj +1 more source
Dyslipidemia refers to an abnormal amount of lipid in the blood, and the total cholesterol level is defined as the sum of high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, and very-LDL cholesterol concentrations.
Su Jin Park, Dong Ho Park
doaj +1 more source
General practice electronic health record (EHR) data have significant potential for clinical research. This study demonstrates the feasibility of utilising longitudinal EHR data analysis to address clinically relevant outcomes and uses the relationship ...
Adam J. Hodgkins +3 more
doaj +1 more source
Novel pyrrolo [2,3-b] pyrrole derivatives were synthesized and their hypolipidemic activity was assessed in hyperlipidemic rats. The chemical structures of the new derivatives were confirmed through spectral analysis.
Moumen S. Kamel +7 more
doaj +1 more source

